Cells trying to keep pace with constantly changing environmental conditions need to strike a fine balance between maintaining their genomic integrity and allowing enough genetic flexibility to adapt to inhospitable conditions…
Lees meer..

Like a magician employing sleight of hand, the protein mitoNEET - a mysterious but important player in diabetes, cancer and aging - draws the eye with a flurry of movement in one location while the subtle, more crucial action takes place somewhere else…
Lees meer..

This unique and timely event will highlight how different frameworks and initiatives have succeeded in developing an efficient, environmentally friendly manufacturing process in the pharmaceutical industry…
Lees meer..

Colorado Economic Development Commission (EDC) members voted Monday to approve nearly $120,000 in incentives for DaVita Inc. to build a research facility in Lakewood for which it plans to hire 58 employees.

The vote follows the dialysis center operator’s confirmation last week that it has chosen the St. Anthony Central Hospital campus as the location for its second U.S. research center.

The center, which will go in one of two medical office plazas under construction on the campus, is expected to employ high-paying executives and medical professionals…

Lees meer..

Charitable giving in the United States jumped 7.5 percent in 2011, with Texas seeing some of the strongest growth at 9.3 percent, according to a report from Dallas-based Atlas of Giving.

Americans gave about $346 billion to charity in 2011. Texas companies and individuals gave about $29 billion, totaling more than all but three states — Florida, Illinois and Pennsylvania.

Rob Mitchell, CEO Atlas of Giving, attributed the state’s strong showing to its economy.

“The unemployment rate in Texas is lower than it is in much of the rest of the United States, there is an increasing population in Texas and you have some major economic development happening — especially in the Barnett Shale and the Eagleford Shale down in South Texas,” Mitchell said…

Lees meer..

Being a research biotech is usually a money-losing proposition.

Investors and executives expect to pour tens of millions of dollars or more into finding and developing promising new drugs. Profits will come later, they hope, when researchers succeed and a drug makes it to market.

But research doesn’t have to pile up losses until a company’s drug bears fruit.

Witness Boulder’s Array BioPharma Inc.

The drug research company (Nasdaq: ARRY) on Monday reported results for the three months that ended Dec…

Lees meer..

This week’s edition of the Phoenix Business Journal, due out Friday, is ranking Arizona’s largest dental insurance companies by number of Arizona enrollees.

Fifth on the list is Blue Cross Blue Shield of Arizona with 139,423 enrollees.

The sneak peek at the rest of the top five continues on Tuesday, Jan. 31.

The dental insurance companies list, along with the list of Arizona hospices, is available to subscribers. Check out pages 15 and 18 of Friday’s paper. If you don’t subscribe, click here…

Lees meer..

Venture-capital investment in Midwest health care startups jumped in 2011, with Minnesota leading the way, according to a report released Monday.

Life-sciences firms across the Midwest pulled in a total of $810 million in financing for the year, up from $739 million in 2010, the study from Cleveland-based BioEnterprise Corp. found. Minnesota came out on top for the year, accounting for $223 million of the total.

The report tracked deals for 11 states and western Pennsylvania. The report examines investments in the medical device, health IT, health care services and biopharmaceuticals industries…

Lees meer..

Kaiser Permanente is gearing up for a statewide strike Tuesday by what could be more than 23,000 workers.

The National Union of Healthcare Workers will strike to draw attention to stalled contract negotiations at five bargaining tables across the state. The California Nurses Association has called a sympathy strike. So has Stationary Engineers Local 39.

Most of the action will be in Northern California. Locally, up to 3,550 Kaiser workers may participate in the walkout, along with 250 behavioral health and optical workers at Kaiser who are members of NUHW…

Lees meer..

After months of hype from Seattle-based biotech Cell Therapeutics Inc. about a second chance at FDA approval for pixantrone, the optimism was absent Monday as the company withdrew its new drug application for the proposed treatment of non-Hodgkin’s lymphoma.

Cell Therapeutics (NASDAQ: CTIC) issued a release saying it needed “additional time” to prepare for the Food and Drug Administration review. The company asked for an extra month to prepare, but the FDA declined to reschedule in that time frame…

Lees meer..